Scientific Papers
OriGene scientists are dedicated to the advancement of biological and medical science. They attend scientific conferences and share their ideas and findings with fellow scientists.
PEGS 2023
Target of Interest | Title | View PDF |
---|---|---|
PSCA | PSCA Expressions in Cancers: A Potential Prognostic Marker and Target for Immunotherapy. |
2023 American Association of Cancer Research
Target of Interest | Title | View PDF |
---|---|---|
MAGEA3 & MAGEA4 | MAGEA3 and MAGEA4 proteins show co-expression in lung, bladder and colon cancer. | |
Inducible vectors | A new generation of inducible all-in-one Tet-On-ORF/shRNA vectors | |
MAGEA3 | MAGE-A3 expression with MMR-MSH6 screening suggests MAGE-A3 as a potential target for microsatellite-stable colorectal cancer. | |
MAGEA3 & MAGEA4 | Colocalization of MAGE-A3 and MAGE-A4 in bladder cancer. |
2022 National Society for Histotechnology
Target of Interest | Title | View PDF |
---|---|---|
MAGEA3 and MAGEA4 | MAGEA3 and MAGEA4 have different expression pattern in lung cancer |
2022 American Association for Clinical Chemistry Meeting
Target of Interest | Title | View PDF |
---|---|---|
MAGE-A3 | Serum MAGE-A3 Is A Potential Prognostic Marker for Prostate Cancer |
2022 American Association of Cancer Research Annual Meeting
Target of Interest | Title | View PDF |
---|---|---|
MAGE | A renewable IHC control tool CytoSection for defining MAGEA3, MAGEA4, and MAGEA9 antibody specificity | |
HSD17B13 | Overexpression of HSD17B13 induced G1 arrest in hepatic cell lines detected by anti-HSD17B13 recombinant rabbit monoclonal antibody |
2020 American Association of Cancer Research Virtual Annual Meeting
Target of Interest | Title | View PDF |
---|---|---|
PD-L1 | PD-L1 and Diacylglycerol Kinase alpha (DGKa) Expression in NSCLC and Bladder Cancer |
2019 American Association of Cancer Research Annual Meeting
Target of Interest | Title | View PDF |
---|---|---|
CRISPR | CRISPR KN2.0: A Universal Solution for Genome-Wide Gene Knockout/Knockin | |
PD-L1 | Immune Cell Expression of LAG3 and TIM3 In The Tumor Micro Environment Of PD-L1 Positive/Negative Bladder Cancer, Melanoma, And Lung Cancer |
2018 American Association of Cancer Research Annual Meeting
Target of Interest | Title | View PDF |
---|---|---|
PD-L1 | Characterization of Two New Recombinant Rabbit anti-PDL1 Antibodies In Bladder Cancer, NSCLC, and Melanoma With Immune Cell Markers CD3, CD8A, CD20, CD68 and FOXP3 |
2016 American Association of Cancer Research Annual Meeting
Target of Interest | Title | View PDF |
---|---|---|
ALK | A new, highly sensitive ALK antibody improves the screening of rearranged-ALK by IHC | |
LGR5 | Evaluation of LGR5 protein expression in colon cancer stem cells | |
HER2 | A screen of breast and colon cancers with HER2 antibody clone UMAB36 does not exhibit the cross-reactivity of clone 4B5 with HER4 protein |
2015 American Association of Cancer Research Annual Meeting
Target of Interest | Title | View PDF |
---|---|---|
ALK | The development of a highly sensitive mouse monoclonal antibody for screening ALK-rearrangements in lung cancers | |
HER2 | Develop a Highly Specific HER2 Antibody for IHC Screening in Breast and Gastric Cancers | |
Ki67 | The Development of a Highly Specific IHC Monoclonal Antibody against Ki-67 | |
MET | The development of a highly specific mouse monoclonal MET antibody for IHC application |
2015 Experimental Biology
Target of Interest | Title | View PDF |
---|---|---|
LGR5 | The Development and Evaluation of Highly Specific Monoclonal Antibodies against Human LGR5 | |
PD-1 | The Development of an Anti-PD1 Mono-Specific Antibody (UMAB199) for Anatomic Pathology |